Mitigating AI Hallucinations in LLMs: A Scoping Review for Clinical and Educational Integration
What the Researchers Tested
This scoping review specifically examined the landscape of AI hallucinations within LLMs as they pertain to medical education and clinical healthcare. The methodology involved a systematic search across PubMed/MEDLINE, Scopus, IEEE Xplore, and Web of Science for English-language publications from January 2018 to July 2026. Two independent reviewers performed study selection and data extraction, synthesizing findings via descriptive thematic analysis. The aim was to elucidate the nature of these inaccuracies, how they are detected, validated, and subsequently mitigated, alongside their broader educational and governance implications. The review categorized its findings into five overarching themes and thirteen subthemes. These included a deep dive into how AI hallucinations manifest in healthcare, the current methods for their detection and rigorous validation, and various strategies employed to enhance the reliability of LLM outputs. Furthermore, the analysis explored the critical need for AI literacy among medical professionals and students, and the development of robust governance, accountability, and trustworthy implementation frameworks to ensure the safe and effective integration of these advanced AI tools into clinical and educational settings.
What the Study Found
Of 2,051 initial records, 21 sources met inclusion criteria, comprising 5 empirical/model-evaluation studies and 16 review/conceptual articles.
Five main themes were identified: conceptualization of hallucinations, detection/validation, mitigation strategies, educational implications, and governance frameworks.
Key mitigation strategies include Retrieval-Augmented Generation (RAG), structured prompt design, rigorous output verification, and essential human oversight.
AI hallucinations are conceptualized as multidimensional challenges extending beyond mere technical errors, impacting safety, integrity, and trust.
Why This Matters to Clinical Practice
The pervasive risk of AI hallucinations directly impacts diagnostic accuracy, treatment planning, and medical education. In clinical settings, an LLM generating an unverified treatment protocol or citing a non-existent study could lead to significant patient harm or misallocation of resources. For medical students and residents, reliance on hallucinated information could undermine foundational knowledge, impair critical thinking, and potentially compromise future clinical competence. From a systems perspective, the unchecked proliferation of hallucinating LLMs threatens to erode trust in AI technologies, hindering their potential to alleviate clinician burden, improve diagnostic efficiency, and personalize medicine. Addressing these 'plausible but inaccurate' outputs is paramount for hospital leadership and department heads, as it directly influences patient safety protocols, educational curriculum design, and the ethical deployment of AI. Effective mitigation and robust governance are essential to harness the transformative potential of LLMs while safeguarding against their inherent risks.
Clinical & Workflow Takeaways
Clinicians and medical educators should adopt a critical approach to LLM-generated content, especially for clinical decision support or educational material requiring factual accuracy. Integrating 'Retrieval-Augmented Generation' (RAG) frameworks where LLMs query verified external knowledge bases can significantly reduce hallucination rates. Furthermore, implementing structured prompt engineering techniques will guide LLMs towards more constrained and accurate outputs. For clinical departments, establishing clear protocols for human oversight and output verification by subject matter experts is crucial before any LLM-derived information is acted upon or disseminated. Medical education curricula must incorporate 'critical AI literacy' training, empowering future healthcare professionals to identify, evaluate, and address potential inaccuracies from AI tools. Governance frameworks must be developed at institutional levels to ensure accountability and transparent implementation of LLMs, fostering a culture of continuous validation and risk assessment.
Limitations and What Remains Uncertain
The scoping review, while comprehensive, is inherently limited by the nature of the included sources, with a majority being review, conceptual, or opinion-based articles (16 of 21). This suggests a relative paucity of robust empirical or model-evaluation studies on AI hallucinations in healthcare. The search period ending July 2026 implies anticipation of future literature, which, at present, might not fully reflect the real-world evolution and challenges of LLM deployment. The exclusion of non-English sources could introduce a linguistic bias, potentially overlooking relevant research from diverse international contexts. Furthermore, the rapid advancements in LLM technology mean that mitigation strategies identified may quickly become outdated, necessitating continuous re-evaluation.
Explore the Work Behind Clinical AI
MedXchange Research Fellowship
Publish Clinical AI Research With Us
Our 10-week fellowship mentors physicians and researchers to build foundation models, analyze multimodal health datasets, and co-author peer-reviewed clinical studies.
Related Clinical AI Stories
LLM Chatbot Offers Promising, Yet Flawed, Allergen Avoidance Guidance in Contact Dermatitis
A recent quantitative evaluation study explored the utility of a Large Language Model (LLM) chatbot, specifically GPT-4, in providing allergen-free product recommendations for patients with contact dermatitis. The study assessed the LLM's ability to recommend products free of 30 common allergen groups found in international standard patch tests. While the chatbot demonstrated a high proportion of valid responses, particularly for cosmetics and medications, clinicians must recognize its limitations, especially concerning complex allergens prone to cross-reactivity. Over a period from September 2023 to January 2024, GPT-4 was prompted to suggest five allergen-free products for each allergen group, utilizing three distinct question formats. Dermatologists manually reviewed and categorized 2250 responses for validity, invalidity, cross-reactions, unknown status, and unresponsiveness. The findings indicate a significant potential for LLM tools to assist in allergen avoidance counseling, albeit with a crucial need for human verification and oversight.
AI's Role in Diagnosing Rare and Undiagnosed Diseases: A Critical Perspective
A recent perspective from the NEJM Catalyst Insights Council highlights the significant potential of artificial intelligence (AI) in accelerating the diagnosis of rare and undiagnosed diseases. These conditions, often individually uncommon, collectively affect a substantial patient population, leading to prolonged diagnostic odysseys, increased healthcare costs, and significant patient morbidity. The Council emphasizes that while AI offers unprecedented capabilities in pattern recognition across vast datasets, it represents only one component of a multifaceted solution required to address this complex clinical challenge. The editorial underscores that the inherent complexity of rare diseases—characterized by phenotypic heterogeneity, genetic variability, and limited epidemiological data—makes them particularly amenable to AI's strengths in identifying subtle correlations and anomalies. However, achieving accurate and timely diagnoses will necessitate more than just technological advancements; it demands integrated strategies encompassing robust data infrastructure, multidisciplinary clinical collaboration, and careful consideration of ethical implications.
LLMs for Atrial Fibrillation Patient Education: Cardiologist vs. Non-Medical Professional Perceptions of ChatGPT and Google Gemini Quality
A recent pilot study published in JMIR Formative Research comparatively analyzed the quality of atrial fibrillation (AF) explanations generated by ChatGPT and Google Gemini, specifically tailored for patient education. The study aimed to assess the overall quality of these AI platforms, compare their responses, and identify differences in perception between cardiologists and non-medical professionals. The prompt, "Explain atrial fibrillation and how to treat it to a patient," was used to generate responses from both AI models. These responses were then evaluated by a cohort of 28 participants, comprising cardiologists/cardiology fellows and non-medical college graduates, using a survey derived from the Patient Education Materials Assessment Tool (PEMAT) and DISCERN criteria, rated on a 5-point Likert scale. The findings indicated no significant overall quality difference between ChatGPT and Google Gemini for AF education. However, crucial discrepancies emerged in how different participant groups evaluated specific aspects. Cardiologists rated AI responses higher for perceived bias and for explaining the consequences of untreated AF, while non-medical professionals favored structural and organizational features such as visual cues, informative headers, concise sections, identifiable patient actions, and references to additional resources. This suggests that while both platforms are viable, their utility in clinical settings requires careful consideration of the target audience and a balanced evaluation by specialists.